Sanofi Stock Attracts Income Investors With Strong Dividend and FDA Approval

Trading below nine times earnings and offering a 5.4% dividend yield, pharmaceutical giant Sanofi recently secured a key FDA approval, drawing attention from value-focused portfolios seeking stable returns.